Compare MGF & CBUS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | MGF | CBUS |
|---|---|---|
| Founded | 1987 | 2010 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Trusts Except Educational Religious and Charitable | Agricultural Chemicals |
| Sector | Finance | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 92.9M | 98.5M |
| IPO Year | N/A | 2017 |
| Metric | MGF | CBUS |
|---|---|---|
| Price | $2.85 | $1.36 |
| Analyst Decision | | Buy |
| Analyst Count | 0 | 2 |
| Target Price | N/A | ★ $9.00 |
| AVG Volume (30 Days) | 134.3K | ★ 278.0K |
| Earning Date | 01-01-0001 | 05-14-2026 |
| Dividend Yield | ★ 7.64% | N/A |
| EPS Growth | N/A | ★ 74.33 |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $3,639,000.00 |
| Revenue This Year | N/A | $112.72 |
| Revenue Next Year | N/A | $83.18 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $2.80 | $1.09 |
| 52 Week High | $3.14 | $4.19 |
| Indicator | MGF | CBUS |
|---|---|---|
| Relative Strength Index (RSI) | 47.78 | 49.33 |
| Support Level | N/A | $1.20 |
| Resistance Level | $2.94 | $1.56 |
| Average True Range (ATR) | 0.04 | 0.10 |
| MACD | 0.00 | 0.01 |
| Stochastic Oscillator | 41.67 | 57.58 |
MFS Government Markets Income Trust is a United States-based diversified, closed-end management investment company. Its investment objective is to seek high current income. The fund invests a majority of the net assets, including borrowings for investment purposes, in U.S. and foreign government securities. The company invest various sectors like U.S. Treasury Securities, Mortgage-Backed Securities, Investment Grade Corporates, Municipal Bonds, Non-U.S. Government Bonds, etc, out of which maximum revenue is gained from U.S. Treasury Securities.
Cibus Inc is a biotechnology company. The company develops and commercializes a proprietary gene-editing technology, Rapid Trait Development System that integrates crop specific cell biology platforms with a series of gene editing technologies. The company's primary business is the development of plant traits that help address specific productivity or yield challenges in farming such as traits addressing plant agronomy, disease, insects, weeds, nutrient-use, or the climate.